AtlasXomics Inc. is commercializing a novel discovery platform that provides clinicians and researchers with unprecedented multi-omics tissue atlases. This innovative platform, called “Deterministic Barcoding in Tissue for spatial omics sequencing” (DBiT-seq), was developed by Dr. Rong Fan, Professor of Biomedical Engineering at Yale University. DBiT-seq leverages microfluidics and next generation sequencing (NGS) to create transformative multi-omic maps (proteomics, transcriptomics, and epigenomics) of tissue to provide information about interactions between cells in localized neighborhoods. AtlasXomics is the first company to offer spatial ATAC-seq and spatial CUT & Tag to map chromatin accessibility and histone modifications across the entire genome in tissue.